Scalable Manufacturing of Functional Islets from hiPSCs

Discover a scalable, reproducible workflow for generating functional hiPSC-derived islets for clinical applications using GMP-grade, animal-free proteins and small molecules. This study demonstrates robust cell expansion, lineage specification, and maturation, with evaluation by automated, high-throughput quality assessment tools to determine characterization, cell identity, and glucose competence.

See how integrated manufacturing and analytical solutions can help advance the development of scalable, clinically relevant cell therapies for diabetes treatment.